Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)

SHE:301258 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	382.73	224.73	349.74	259.69	332.06	98.09
Trading Asset Securities	950.41	1,123	1,070	1,161	21.61	120
Cash & Short-Term Investments	1,333	1,348	1,419	1,421	353.67	218.09
Cash Growth	-3.65%	-5.04%	-0.10%	301.69%	62.17%	0.96%
Accounts Receivable	95.25	101.35	62.91	97.02	87.87	79.73
Other Receivables	0.74	0.84	0.93	0.85	2.05	1.45
Receivables	95.98	102.19	63.84	97.87	89.92	81.18
Inventory	123.32	154.83	157.09	122.69	68.6	60.12
Other Current Assets	9.89	6.75	8.59	8.55	4.41	13.6
Total Current Assets	1,562	1,612	1,649	1,650	516.6	372.98
Property, Plant & Equipment	496.95	398.91	387.62	416.11	421.15	381.61
Long-Term Investments	0.2	5	26.27	-	-	-
Other Intangible Assets	61.2	62.56	21.24	21.97	22.07	22.7
Long-Term Deferred Tax Assets	0.01	0.07	0.01	0	1.61	1.35
Long-Term Deferred Charges	2.33	3.28	4.55	-	-	-
Other Long-Term Assets	31.42	6.34	27.58	10.49	8.88	9.61
Total Assets	2,154	2,088	2,116	2,098	970.31	788.25
Accounts Payable	165.09	118.25	84.97	114.86	124.96	90.86
Accrued Expenses	13.69	19.16	19.48	18.47	17.85	15.71
Short-Term Debt	-	-	-	-	18.58	-
Current Portion of Leases	0.7	0.66	0.59	0.56	-	-
Current Income Taxes Payable	0.95	4.49	1.33	3.4	3.9	-
Current Unearned Revenue	1.22	1.42	2.07	6.49	6.73	3.49
Other Current Liabilities	0.78	1.27	3.66	6.12	1.15	0.92
Total Current Liabilities	182.43	145.25	112.1	149.91	173.17	110.98
Long-Term Leases	0.48	1.01	1.67	2.25	-	-
Long-Term Unearned Revenue	34.7	36.99	35.27	38.38	36.42	38.95
Long-Term Deferred Tax Liabilities	25.21	17.6	21.41	21.21	17.88	15.68
Total Liabilities	242.82	200.84	170.45	211.75	227.47	165.61
Common Stock	91.67	91.67	91.67	91.67	68.75	68.75
Additional Paid-In Capital	1,144	1,144	1,144	1,144	163.42	163.42
Retained Earnings	736.89	671.75	710.32	651.31	510.67	390.47
Treasury Stock	-60.56	-20.14	-	-	-	-
Shareholders' Equity	1,912	1,887	1,946	1,887	742.84	622.64
Total Liabilities & Equity	2,154	2,088	2,116	2,098	970.31	788.25
Total Debt	1.18	1.67	2.25	2.82	18.58	-
Net Cash (Debt)	1,332	1,346	1,417	1,418	335.09	218.09
Net Cash Growth	-3.61%	-5.00%	-0.06%	323.12%	53.65%	0.96%
Net Cash Per Share	14.74	14.77	15.41	16.47	4.88	3.17
Filing Date Shares Outstanding	89.68	90.82	91.67	91.67	68.75	68.75
Total Common Shares Outstanding	89.68	90.82	91.67	91.67	68.75	68.75
Working Capital	1,380	1,466	1,537	1,500	343.43	262
Book Value Per Share	21.32	20.78	21.22	20.58	10.80	9.06
Tangible Book Value	1,850	1,824	1,924	1,865	720.76	599.94
Tangible Book Value Per Share	20.63	20.09	20.99	20.34	10.48	8.73
Buildings	-	254.18	253.42	251.56	253.49	189.23
Machinery	-	470.51	454.95	436.91	384.41	360.9
Construction In Progress	-	38.15	1.49	0.43	12.17	17.58
Order Backlog	-	81.26	-	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.